Cantor Fitzgerald Reiterates Overweight Rating on Surgery Partners (SGRY)

Cantor Fitzgerald analyst Sarah James reiterated an Overweight rating and $36.00 price target on Surgery Partners (NASDAQ: SGRY).

The analyst commented, “View SGRY data as either suggesting 1) outperforming peers as positions and bonuses come down Q/Q vs. peers stable and increasing, or 2) hiring is slowing, which could be an indicator of the probability of the pending offer going through.”

For an analyst ratings summary and ratings history on Surgery Partners click here. For more ratings news on Surgery Partners click here.

Shares of Surgery Partners closed at $23.54 yesterday.

You May Also Be Interested In

• NVIDIA, Mitsubishi Heavy Industries eye cooperation on AI data center cooling and power - Nikkei
• Manpower Inc. (MAN) PT Raised to $41 at UBS Ahead of Q2 Earnings
• Cantor Fitzgerald Reiterates Overweight Rating on Nova Measuring Instruments (NVMI)